Abstract：Objective To explore the clinical effect of Tongxinluo Capsules on cerebral infarction patients with the syndrome of qi deficiency and blood stasis. Methods A total of 80 cerebral infarction patients with the syndrome of qi deficiency and blood stasis from June 2019 to May 2020 in the People’s Hospital of Huaiyin, Shandong Province were selected as the research objects, and they were randomly divided into control group (40 cases) and research group (40 cases). The control group received conventional Western medicine treatment, and the research group received Tongxinluo Capsules on the basis of the control group. After 28 d of treatment, limb motor function, walking ability, nerve damage situation, and self-care ability of two groups were evaluated. Results There were two cases of detachment, all male patients in the study group. After treatment, Fugl-Meyer motor scale scores of upper and lower limbs in the two groups were higher than those before treatment, and those in the study group were higher than those in the control group (P ＜ 0.05). After treatment, the scores of walking ability in the two groups were lower than those before treatment, and that in the study group was lower than that in the control group (P ＜ 0.05). After treatment, the scores of National Institutes of health stroke scale in the two groups were lower than those before treatment, and that in the study group was lower than that in the control group (P ＜ 0.05). After treatment, the scores of daily living activities in the two groups were higher than those before treatment, and that in the study group was higher than that in the control group (P ＜ 0.05). Conclusion Tongxinluo Capsules can improve the limb motor function and self-care ability of cerebral infarction patients with the syndrome of qi deficiency and blood stasis, promote the recovery of patients’ cerebral nerve function, help to improve the clinical treatment effect, and is worthy of clinical application.
京公网安备 11010502046598号